1,028
Participants
Start Date
October 21, 2021
Primary Completion Date
April 4, 2022
Study Completion Date
April 4, 2022
RSVpreF (Group 1)
RSV vaccine (RSVpreF)
RSVpreF (Group 2)
RSV vaccine (RSVpreF)
RSVpreF (Group 3)
RSV vaccine (RSVpreF)
Placebo
Placebo
Accellacare - Wilmington, Wilmington
Clinical Research Atlanta, Stockbridge
Clinical Site Partners, Inc, Winter Park
Clinical Site Partners, Winter Park
Global Health Research Center, Inc., Miami Lakes
Precision Clinical Research, Sunrise
Kentucky Pediatric/ Adult Research, Bardstown
Aventiv Research Inc, Columbus
Sundance Clinical Research, St Louis
Meridian Clinical Research, LLC, Omaha
Texas Center for Drug Development, Inc., Houston
DM Clinical Research, Tomball
Benchmark Research, Austin
Clinical Research Prime, Idaho Falls
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
East-West Medical Research Institute, Honolulu
Velocity Clinical Research, Providence, East Greenwich
Lead Sponsor
Pfizer
INDUSTRY